...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Expression of retinoblastoma gene (Rb) protein in T12M0 prostatic adenocarcinoma.
【24h】

Expression of retinoblastoma gene (Rb) protein in T12M0 prostatic adenocarcinoma.

机译:视网膜母细胞瘤基因(Rb)蛋白在T12M0前列腺腺癌中的表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The expression of Rb protein was analysed by immunocytochemical methods in 118 patients with T12M0 prostatic adenocarcinoma who were followed-up for more than 12 years. Rb protein was expressed in 117/118 (99%) tumours. The fraction of positive nuclei was (mean +/- SD, 92 +/- 19%) and only one tumour was completely negative for Rb protein. Abnormal expression of the Rb protein (in fewer than 90% of cells) was independent of the T category while there was a significant relationship between DNA ploidy (P = 0.0138), S-phase fraction (P = 0.0042) and expression of the Rb protein. Abnormal expression of the Rb protein had no prognostic value while T category (P = 0.0017), Gleason score (P = 0.0097), DNA ploidy (P = 0.0034), S-phase fraction (P = 0.0179) and mitotic index (P = 0.0001) were significant prognostic factors. In multivariate analysis the only independent predictor was the mitotic index [Risk ratio (RR) (95%CI) = 7.4(2.4-22.5), P = 0.004]. The results show that Rb protein immunohistochemistry has hardly any prognostic significance in prostatic adenocarcinoma whereas direct measurement of cell proliferative activity contains significant prognostic information.
机译:通过免疫细胞化学方法分析118例T12M0前列腺腺癌患者的Rb蛋白表达,随访时间超过12年。 Rb蛋白在117/118(99%)肿瘤中表达。阳性细胞核比例为(平均值+/- SD,92 +/- 19%),只有一个肿瘤的Rb蛋白完全阴性。 Rb蛋白的异常表达(少于90%的细胞)与T类别无关,而DNA倍性(P = 0.0138),S期分数(P = 0.0042)和Rb的表达之间存在显着关系。蛋白。 Rb蛋白的异常表达没有预后价值,而T类(P = 0.0017),格里森评分(P = 0.0097),DNA倍性(P = 0.0034),S期分数(P = 0.0179)和有丝分裂指数(P = 0.0001)是重要的预后因素。在多变量分析中,唯一的独立预测因子是有丝分裂指数[风险比(RR)(95%CI)= 7.4(2.4-22.5),P = 0.004]。结果表明,Rb蛋白免疫组织化学在前列腺腺癌中几乎没有任何预后意义,而直接测量细胞增殖活性则包含重要的预后信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号